(R)-2-Methoxy-N-(piperidin-3-yl)acetamide hydrochloride, 95.0%, 1g

Potassium tert-butyltrifluoroborate, 95.0%, 1g

3-Nitro-1H-pyrazolo[3,4-b]pyridine, 95.0%, 10g

Cloruro de cobre (II) dihidrato, mínimo 99%, pa, 500 g, envase de plástico.

BALOXAVIR, 95%, 1g

1-(10H-Phenothiazin-2-yl)ethanone, 95.0%, 5g

1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate, 95.0%, 10g

2,6-Dibromopyridine-4-carboxylic acid hydrobromide, 1g

2-Amino-N,N,4-trimethylpentanamide hydrochloride, 95%, 1g

3-Iodophenylacetic Acid>98.0%(GC)(T)1g

N-1-Boc-N-4-Cbz-2-Piperazine carboxylic acid, 97.0%, 10g

4-Hydroxyisophthalaldehyde, 95.0%, 10g

1-(Cyclohexanecarbonyl)piperidine-3-carboxylic acid, 95%, 250mg